NSAID Tablet in pharma franchise in Thiruvananthapuram

NSAID Tablet in PCD pharma franchise in Maharashtra

NSAID Tablet in top pharma company in Mumbai

NSAID Tablet in pcd pharma supplier in Mysore

NSAID Tablet in phama franchise company in India
NSAID Tablet in phama distributor in Mandi

Home/Products /diclofenac-50mg-paracetamol-325mg-serratiopeptidase-10mg-tablet

Decplist SP Tablet

Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹102/-

Decplist SP Tablet is a combination medication designed to alleviate pain and inflammation. Each tablet contains 50 mg of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) that effectively reduces pain and swelling. Paracetamol, present at 325 mg, enhances analgesic effects and is widely recognized for its ability to relieve mild to moderate pain and reduce fever. Serratiopeptidase, at 10 mg, is a proteolytic enzyme that aids in reducing inflammation and accelerating the healing process by breaking down protein molecules that accumulate in injured tissues.

This formulation is ideal for individuals suffering from conditions such as arthritis, muscle pain, dental pain, or post-operative discomfort. The synergistic action of diclofenac and paracetamol provides dual benefits, offering significant relief from pain while addressing the underlying inflammation. Serratiopeptidase complements these effects by further promoting recovery through its anti-inflammatory properties.

Read More

About the Product

Decplist SP Tablet is a combination medication designed to alleviate pain and inflammation. Each tablet contains 50 mg of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) that effectively reduces pain and swelling. Paracetamol, present at 325 mg, enhances analgesic effects and is widely recognized for its ability to relieve mild to moderate pain and reduce fever. Serratiopeptidase, at 10 mg, is a proteolytic enzyme that aids in reducing inflammation and accelerating the healing process by breaking down protein molecules that accumulate in injured tissues.

This formulation is ideal for individuals suffering from conditions such as arthritis, muscle pain, dental pain, or post-operative discomfort. The synergistic action of diclofenac and paracetamol provides dual benefits, offering significant relief from pain while addressing the underlying inflammation. Serratiopeptidase complements these effects by further promoting recovery through its anti-inflammatory properties.

Common side effects may include gastrointestinal discomfort, nausea, dizziness, and allergic reactions. Serious side effects should be reported to a healthcare provider immediately.

Decplist SP Tablet is indicated for the relief of pain and inflammation associated with conditions like arthritis, muscle injuries, and post-surgical pain.

Consult your healthcare professional before using this medication, especially if you have existing health conditions or are taking other medications. In summary, Decplist SP Tablet combines the potent effects of diclofenac, paracetamol, and serratiopeptidase to provide comprehensive relief from pain and inflammation. Always use this medication as directed by your healthcare provider to ensure safety and efficacy. Regular monitoring and follow-ups may be necessary to adjust dosage and manage any potential side effects.

Store in a cool, dry place away from direct sunlight and moisture, ensuring it is kept out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation